TABLE 6.
Results of network meta‐analysis of wound infection cases.
| Intervention measures | 20 μg/cm2 repifermin | 60 μg/cm2 repifermin | Antiseptic ointment dressing | APG | LeucoPatch | PPP | PRP | CT |
|---|---|---|---|---|---|---|---|---|
| 20 μg/cm2 repifermin | 0 | |||||||
| 60 μg/cm2 repifermin | −0.85 (−5.5, 3.71) | 0 | ||||||
| Antiseptic ointment dressing | −2.71 (−9.7, 4.04) | −1.86 (−8.78, 4.84) | 0 | |||||
| APG | 32.59 (2.42, 77.68) | 33.5 (3.31, 78.54) | 35.44 (5.03, 80.43) | 0 | ||||
| LeucoPatch | −1.5 (−7.71, 4.71) | −0.63 (−6.77, 5.4) | 1.21 (−5.4, 8.02) | −34.18 (−79.14, −3.98) | 0 | |||
| PPP | −2.34 (−9.81, 4.7) | −1.48 (−8.86, 5.51) | 0.38 (−6.52, 7.12) | −35.09 (−80.19, −4.5) | −0.82 (−8.13, 6.08) | 0 | ||
| PRP | −1.27 (−6.59, 3.82) | −0.41 (−5.61, 4.55) | 1.43 (−3.04, 5.99) | −33.98 (−78.85, −4.04) | 0.23 (−4.8, 5.1) | 1.03 (−3.91, 6.34) | 0 | |
| CT | −1.8 (−6.4, 2.66) | −0.95 (−5.38, 3.42) | 0.91 (−4.19, 6.19) | −34.53 (−79.24, −4.68) | −0.3 (−4.55, 3.9) | 0.52 (−4.98, 6.43) | −0.53 (−3.02, 2.08) | 0 |
Abbreviations: APG, autologous platelet gel; CT, conventional treatment; PPP, platelet‐poor plasma; PRP, platelet‐rich plasma.